Beta-Blockers: Current State of Knowledge and Perspectives

Author(s): Magdalena Ogrodowczyk, Katarzyna Dettlaff, Anna Jelinska

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 16 , Issue 1 , 2016

Become EABM
Become Reviewer
Call for Editor


It has been over half a century since propranolol, the first beta-blocker, was developed for medical treatment. Since that time a large number of compounds from this group have been synthesised and many are now in clinical use. The structure, function, pharmacokinetics, and mechanism of beta-blockers have been established. The possibilities for their use in treating different conditions continue to evolve. Since the discovery of later generation beta-blockers, such as carvedilol and nebivolol, the search for new compounds continues, and may include known substances with betablocking properties which could extend their therapeutic potential.

Keywords: Activity, application, aryloxyaminopropanol derivatives, beta-blockers, structure.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 29 October, 2015
Page: [40 - 54]
Pages: 15
DOI: 10.2174/1389557515666151016125948
Price: $65

Article Metrics

PDF: 141
HTML: 44
PRC: 1